Similar articles

Abstract: Background: The purpose of this study was to describe our experiences and analyze the benefits of video-assisted thoracoscopic surgery (VATS) combined with positron emitted tomography (PET)-computed tomography (CT) in the diagnosis of patients with early (Stage 1) sarcoidosis. Methods: From 1995 to 2006, seven patients (two males, five females), with ages ranging from 26 to 58 years, were impressed with Stage 1 sarcoidosis (mediastinal or hilar lymph nodes involvements without lung involvement) by histological examination of intrathoracic lymph nodes (LNs) and/or lung parenchyma taken from VATS biopsy. Three of them received PET or PET-CT evaluation. VATS was approached from the right and left side in one and six patients, respectively, according to the locations of their lesions. Results: All the VATS biopsied LNs or lung specimens were adequate for establishing diagnosis. Mediastinal LNs were taken from Groups 3, 4 in four, Group 7 in two, and Groups 5, 6 in one of them. Hilar LNs biopsies were performed in four cases. Lung biopsy was performed in all but two cases. All of them were expressed pathologically or radiologically as Stage 1 sarcoidosis. PET-CT revealed high emission signals over these affected LNs. These patients received oral steroid treatment or follow up only. All of them were followed up from 5 months to 11 years with satisfactory results. Conclusion: VATS biopsy is a minimally invasive, safe and effective procedure. It can be used as a diagnostic alternative of transbronchial lung biopsy (TBLB), and can harvest larger and more areas of specimens than mediastinoscopy for staging patients with sarcoidosis. PET-CT can provide us more accurate information about the characteristics and localization of these lesions before biopsy. VATS combined with PET-CT can provide more accurate and earlier diagnosis of patients with unknown intrathoracic lesions, including the sarcoidosis.

[1] ATS (American Thoracic Society), 1999. Statement on Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. February 1999. Am. J. Respir. Crit. Care Med., 160(2):736-755.

[2] Beyer, T., Townsend, D.W., Brun, T., Kinahan, P.E., Charron, M., Roddy, R., Jerin, J., Young, J., Byars, L., Nutt, R., 2000. A combined PET/CT scanner for clinical oncology. J. Nucl. Med., 41:1369-1379.

[3] Brigid, G.A., Flanagan, F.L., Dehdashti, F., 1997. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. AJR, 169:1675-1680.

[4] Cosabel, U., 2001. Sarcoidosis: clinical update. Eur. Respir. J. Suppl., 18(32):56s-68s.

[5] Geraint James, D., Figueroa Lebron, R.E., 1979. Update on sarcoidosis. Bol. Asoc. Med. P. R., 71:325-335.

[6] Gilman, M.J., Wang, K.P., 1980. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Ann. Rev. Respir. Dis., 122:721-724.

[7] Gould, M.K., Kuschner, W.G., Rydzak, C.E., Maclean, C.C., Demas, A.N., Shigemitsu, H., Chan, J.K., Owens, D.K., 2003. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer. Ann. Intern. Med., 139:879-892.

[8] Hutchinson, J., 1877. Anomalous Disease of the Skin of the Fingers. Papillary Psoriasis. In: Hutchinson, J. (Ed.), Illustrations of Clinical Surgery. J and A Churchill, London.

[9] Johns, C.J., Scott, P.P., Schonfeld, S.A., 1989. Sarcoidosis. Annu. Rev. Med., 40(1):353-371.

[10] Kuznitsky, E., Bittorf, A., 1915. Boecksches sarkoid mit beteligung innerer organe. Munch. Med. Wochenschr., 62:1349-1352.

[11] Lim, J.W.M., Keng, G.H.W., 2005. False positive F-18 fluorodeoxyglucose combined PET/CT scans from suture granuloma and chronic inflammation: report of two cases and review of literature. Ann. Acad. Med. Singapore, 34:457-460.

[12] Lofgren, S., 1953. Primary pulmonary sarcoidosis. Acta Med. Scand., 145:424-431.

[13] Luh, S.P., Liu, H.P., 2006. Video-assisted thoracic surgery—the past, present status and the future. J. Zhejiang Univ. Sci. B, 7(2):118-128.

[14] Mack, M.J., Aronoff, R., Acuff, T., 1992. The present role of thoracoscopy in the diagnosis and treatment of diseases of the chest. Ann. Thorac. Surg., 54:405-409.

[15] Martin, W.J., Iannuzzi, M.D., Gail, D.B., Peavy, H.H., 2004. Future directions in sarcoidosis research. Am. J. Respir. Crit. Care Med., 170(5):567-571.

[16] Massone, P.P.B., Lequaglie, C., Magnani, B., Ferro, F., Ctaldo, I., 2003. The real impact and usefulness of video-assisted thoracoscopic surgery in the diagnosis and therapy of clinical lymphadenopathies of the mediastinum. Ann. Surg. Oncol., 10(10):1197-1202.

[17] McNeill, T., Chamberlain, J., 1966. Diagnostic mediastinotomy. Ann. Thorac. Surg., 2:532-539.

[18] Messa, C., Ceresoli, G.L., Rizzo, G., Artioli, D., Cattaneo, M., Castellone, P., Gregorc, V., Picchio, M., Landoni, C., Fazio, F., 2005. Feasibility of [¹⁸F] FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Q. J. Nucl. Med. Mol. Imaging, 49:259-266.

[19] Miller, B.H., Rosado-de-Christenson, M.L., McAdams, H.P., Fishback, N.F., 1995. Thoracic sarcoidosis: radiologic-pathologic correlation. Radiographics, 15(2):421-437.

[20] Nakayama, T., Hachisuka, H., Furuichi, S., Akusawa, H., Omori, C., Kayama, Y., Nomura, Y., Omori, K., Horie, T., 2000. Sarcoidosis differentially diagnosed from mediastinal tumor by thoracoscopic biopsy. Nihon. Kokyuki. Gakkai. Zasshi., 38:131-135.

[21] Newman, L.S., Rose, C.S., Maier, L.A., 1997. Sarcoidosis. N. Engl. J. Med., 336(17):1224-1234.

[22] Nishimura, K., Itoh, H., Kitaichi, M., Nagai, S., Izumi, T., 1993. Pulmonary sarcoidosis: correlation of CT and histopathologic findings. Radiology, 189:105-109.

[23] Nishiyama, Y., Yamamoto, Y., Fukunaga, K., Takinami, H., Iwado, Y., Satoh, K., Ohkawa, M., 2006. Comparative evaluation of ¹⁸F-FDG PET and 67 Ga scintigraphy in patients with sarcoidosis. J. Nucl. Med., 47:1571-1576.

[24] Ohmichi, M., 2002. Histologic diagnosis of sarcoidosis. Nippon. Rinsho., 60:1759-1765.

[25] Paramothayan, S., Jones, P.W., 2002. Corticosteroid therapy in pulmonary sarcoidosis: a systemic review. JAMA, 287(10):1301-1307.

[26] Reich, J.M., 2003. What is sarcoidosis. Chest, 124(1):367-371.

[27] Rizzo, G., Cattaneo, M., Castiglioni, I., Reni, M., 2001. Integration of CT/PET Images for the Optimization of Radiotherapy Planning. Engineering in Medicine and Biology Society. Proceedings of the 23rd Annual International Conference of the IEEE. Istanbul, Turkey.

[28] Schrevens, L., Lorent, N., Dooms, C., Vansteenkiste, J., 2004. The role of PET scan in diagnosis, staging, and management of non-small-cell lung cancer. Oncologist, 9(6):633-643.

[29] Sharma, A., Fidias, P., Hayman, L.A., Loomis, S.L., Taber, K.H., Aquino, S.L., 2004. Patterns of lymphadenopathy in thoracic malignancies. Radiographics, 24(2):419-434.

[30] Shreve, P.D., Anzai, Y., Wahl, R.L., 1999. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics, 19(1):61-77.